Sitemap - 2012 - The California Stem Cell Report
San Diego Newspaper Calls for Major Changes at California Stem Cell Agency
Boxing in the California Stem Cell Board
Exploring the Straw Man Argument Against IOM Reforms at California Stem Cell Agency
Balloting Begins on Stem Cell Person of the Year
California Editorial Unamity: Stem Cell Agency Needs Revamp
Southern California Newspaper Tackles Stem Cell Agency and UC Irvine Grants
Two More Editorials: The California Stem Cell Agency Should Heed IOM Recommendations for Reform
Meager Coverage of Yesterday's Bristling IOM-CIRM Meeting
Appeals at the California Stem Cell Agency: Worthwhile or Worthless?
LA Times: On the California Stem Cell Agency and Wasting $700,000
Winners From Today's Awards by the California Stem Cell Agency
ViaCyte Wins Another $3 Million from California Stem Cell Agency
California Stem Cell Directors Adjourn Meeting
Constitutional Questions Raised on Sweeping Changes at the California Stem Cell Agency
CIRM Directors Approve $36.2 Million in Stem Cell Grants
CIRM Directors Discussing $36 Million in Grants
A Singular Scientific Story: Duchenne's Disease, a Family and the California Stem Cell Agency
Some California Stem Cell Board Members Bristle at IOM Recommendations
IOM Report: Many Major Changes at Stem Cell Agency Require Legislation
Stem Cell Board Meeting Begins
Covering the California Stem Cell Agency from Panama
Sacramento Bee and IOM: Restructuring Needed at California Stem Cell Agency
Coming Up: Live Coverage of IOM Presentation to Directors of the California Stem Cell Agency
Neil Littman: New Business Development Officer at the California Stem Cell Agency
StemCells, Inc., and California Stem Cell Agency Remain Stalled over $40 Million
IOM-Stem Cell Agency Coverage Planned for Tomorrow
Four Researchers File Appeals with Stem Cell Board for Millions of Dollars
IOM Report: Chronicle Says Prompt and Major Changes Needed at Stem Cell Agency
California Stem Cell Agency: Two Researchers Seek to Overturn Grant Review Rejection
$40 Million High-Risk Stem Cell Research; IOM and CIRM on Engaging Biotech Biz
Stem Cell Agency Chairman Says IOM Report 'Quite Complimentary'
IOM Proposals for Overhaul at CIRM Win High Marks
Text of Comments Reacting to IOM Report on California Stem Cell Agency
More IOM-CIRM Coverage: One Story Notes Major 2007 Conflict Flaps at Stem Cell Agency
Coverage of the IOM Report: Light but a Column with a Cutting Edge
The IOM and the CIRM Point of View
IOM Recommends Sweeping Changes at California Stem Cell Agency
Text of CIRM Chairman's Comments on the IOM Report
Excerpts from the IOM Report on the California Stem Cell agency
Upcoming Tomorrow Morning: IOM Performance Review of the California Stem Cell
Collapse of Big Pharma Deal Involving California Stem Cell Agency
Extra, Extra! CIRM Staffers Blog the World Stem Cell Summit
$80 Million in Grants, Money for Viacyte and Blue-Ribbon Report on California Stem Cell Agency
Update on Move To Curb Researcher Appeals at California Stem Cell Agency
Stem Cell Board Members Lubin and Sheehy Honored
Diane Winokur, Veteran ALS Patient Advocate, Named to California Stem Cell Agency Board
Knoepfler Award Update: More than a Baker's Dozen Nominated
California Stem Cell Agency Still in Talks on $40 Million for StemCells, Inc.
Texas Flap Looms Over California Stem Cell Agency's Grant Appeals
Pomeroy Moving On, Will Leave Stem Cell Board
'The Knoepfler Award:' Recognizing Risk and Those Who Make a Difference
California Stem Cell Agency Blogs on Geron Clinical Trial
Researcher Alert: Keeping Tabs on the Stem Cell Exchequer
BioTime Will Have to Compete for California Cash for Geron's Dormant Clinical Trial
Geron, BioTime Deal Moves Forward with Letter of Intent
Study of California Stem Agency Likely to be Released in About a Month
Geron Weighs Biotime Bid for hESC Biz
Biotime-Geron Deal Attracts Interest from Brit Investor
California Stem Cell Agency First: Big Pharma Hook Up
Viacyte, bluebirdbio Win About $10 Million Each from California stem cell agency
Trounson Going Halftime in January and February
Athersys Appeals California Rejection of $8 Million Proposal
Texas Science Flap Cited as California Stem Cell Agency Eyes its Own Processes
BioTime Makes Bid for Geron's Stem Cell Assets
California Stem Cell Agency Boosting Disease Team Program to $543 Million
Los Angeles Times: StemCells, Inc., Award 'Redolent of Cronyism'
Researcher Alert: Stem Cell Agency to Take Up Grant Appeal Restrictions
Yamanaka and the Frailty of Peer Review
Yamanaka: 'Rejected, Slow and Clumsy'
Tighter Controls on Stem Cell Grant Budgets Hits Quorum Bump
Stem Cell Orthodoxy and Peer Review
Researcher Alert: California Stem Cell Agency Tightening Budget Oversight on Grants
UCD's Knoepfler's 'Somewhat Provocative Paper' on iPS
Fortune Magazine on California Stem Cell Agency: Warm, Personal and Favorable
$700,000 Blue-ribbon Study of CIRM All But Finished
October CIRM Board Meeting Moved to Burlingame
CIRM Sponsoring Online Session with FDA on Thursday
$1.5 Billion in Stem Cell Awards Goes to Directors' Institutions
Text of Comments on Awards to Stem Cell Directors' Institutions
Reproducing Research Results: Removing a Scientific Roadblock
Road to Commercialization: California Stem Cell Agency Seeking Top Level Product Development Execs
StemCells, Inc., Discloses How it Will Generate $40 Million in Matching Funds
California Stem Cell Firsts: From Emotional Appeals to $40 Million Awards
StemCells, Inc., Gunning for Another $10 Million from California Stem Cell Agency
Arm-twisting and Emotion: Stem Cell Directors Move to Reform Appeals on Multimillon Dollar Grants
California Stem Cell Board Adjourns
CIRM Posts Press Release on Board Actions
California Stem Cell Agency Okays $38 Million for Basic Research
Florida Researcher Wins $6.7 Million Grant to Come to Golden State
Board Concludes Private Session on Recruitment Grant
Dennis Steindler Application: Excerpt from Review Summary
CIRM Board Eyes Florida Researcher for $6.7 Million Grant
Two Additional Appeals Rejected in Disease Team Round
Operator Error by Blog ! CIRM Audiocast Up
CIRM Governing Board Meeting: Audiocast Problems
StemCells, Inc., Hails $40 Million in Awards from California Stem Cell Agency
StemCells, Inc., Wins Another $20 Million From California Stem Cell Agency
CIRM Executive Session on StemCells, Inc., Appeal
USC Loses Appeal on $20 Million Proposal
UCLA's Nelson and Miceli Win $6 Million from California Stem Cell Agency
UC Irvine's Klassen Wins $17.3 Million from California Stem Cell Agency
Capricor Wins $20 Million from California Stem Cell Agency
Discussion of Disease Team Appeals Begins
Busy Agenda Tonight for CIRM Directors
Routine Reports Being Heard at CIRM Directors Meeting
Upcoming Coverage of Action on $243 Million Disease Grants
Appeals in $243 Million Stem Cell Round Climb to a Record 11
Good News on Three Appeals; Not-so-Good News for StemCells Inc. and Klein
Seven Researchers Appeal in $35 Million California Stem Cell Round
Serrano Sewell Confirms Departure from Stem Cell Agency
A Business Perspective on Stem Cell Grant Appeals
California Stem Cell Agency: A New Board Member and a New Vacancy
Bob Klein, "Lobbying" and Reader Reaction
Nearly $6 Million Sought: Four Scientists Seek to Overturn Rejection by CIRM Reviewers
Stem Cell Agency Moving to Curb Free-Wheeling Appeals by Researchers
USC Researchers Appeal Rejection of $20 Million Proposal
Researcher Alert: Troubling CIRM Grant Appeal Process Up for Revision
CIRM Board Member Prieto Defends Klein's Right to Appear Before Board
An Unseemly Performance: Former Chair of Stem Cell Agency Promotes $20 Million Research Proposal
Text of Klein's Response to Questions Concerning His Advocacy on Rejected Grant Applications
Text of Klein's Comments Supporting Rejected Applications
CSCR Reading List: A Look at the Grant Appeal Process at the California Stem Cell Agency
$70 Million Research Proposal Up Next Week at California Stem Cell Agency
Researcher Alert: Opportunity for Fresh Appeal in $243 Million Disease Team Round
Stem Cell Blowback from Proposition 71
$20 Million in Stem Cell Irony
News Coverage of CIRM Awards: Substantial but Not Extensive
Coverage of Directors Meeting Concludes
Two More Disease Team Applications Sent Back for More Review
Disease Team Round Hits $151 Million with Final Action
CIRM Directors Continue Discussion on Disease Team Grants
Stem Cell Directors Approve $151 Million to Commercialize Stem Cell Research
CIRM Board in Executive Session
Harvard's McMahon on His Way to USC
$18 Million Cedars Sinai ALS Proposal Headed for Approval
StemCells, Inc., and Capricor Stave Off Rejection from Stem Cell Agency
Stem Cell Directors Order More Consideration on $20 Million UCLA Research Application
Rejected Grants May Be Sent Back for More Review
Discussion Beginning on Disease Team Grants
Short-term Borrowing to Continue to Provide California Stem Cell Cash
California Stem Cell Directors Open Meeting
Live Coverage of Today's CIRM Board Meeting
The Harsh Message at the California Stem Cell Agency
Riding the Stem Cell Financial Wave in Newark
Live Coverage for Tomorrow's Board Meeting of the California Stem Cell Agency
Record Appeals by Researchers in Huge California Stem Cell Agency Round
California Stem Cell Agency Shy This Week on Openness
From Patient Advocates to Presidents: Decision-making Roles on Billions in Research
$70 Million Translational Round Proposed by California Stem Cell Agency
Researcher Alert: Grant Rule Changes at Stem Cell Agency
Royalty Rules at the California Stem Cell Agency: Business Friendly Changes Proposed
California's $12.4 Million Stem Cell Recruitment Lure
UC Davis Researchers Score Big in $113 Million Stem Cell Award Round
California Stem Cell Report Going Dark for a Few Weeks
Parsing Geron's Stem Cell Foray: A Nature Journal Commentary
The California Stem Cell Agency and an HIV Cure: Pushing for a Clinical Trial in 2014
$30 Million Round Attracts Strong Industry Interest; More Cash Coming?
Stem Cell Agency and its $2.4 Million Legal Costs: Proposal to Add Staff Lawyer Slips Away
Finding on 'Evil' Stem Cells Boosts Stem Cell Agency PR
Business-friendly Changes Proposed for Revenue Sharing by Stem Cell Agency
Business Success Rate at Stem Cell Agency: Zero in Latest Round After 14 Fail
'Ugly' Stem Cell Headlines and a Stem Cell Essay Contest
Two California Stem Cell Agency Directors Plump for Proposition 29
Stem Cell Miracles and Campaign Promises : Thomas-Trounson vs. Hiltzik of the Times
California Stem Cell Agency Fires Back at LA Times Columnist
The Market's Invisible Hand and Its Impact on Stem Cell Research
California Stem Cell Hoopdedoo Over Rick Perry: Strange Bedfellows and Education of Politicians
CIRM Board Member Prieto Endorses Proposition 29
A Look at the 'Son of CIRM' Proposal on the June California Ballot
Thin Coverage of California Stem Cell Board Meeting
'Sun Never Sets on CIRM' – California Agency Awards $69 Million to Researchers
Stem Cell Agency Board Sticks with More Financial Disclosure
California Stem Cell Agency Launches Five-Year Push for Cures
CIRM Directors Pleased with Performance Audit Findings
CIRM Board Opens Today's Meeting
Live Coverage of Tomorrow's California Stem Cell Meeting
Michael J. Fox Backs Away From Stem Cell Cure for Parkinson's
Third Researcher Appealing Grant Rejection to Stem Cell Agency Board
Stem Cell Agency Hires Tech Chief to Solve a Myriad of Problems
Painful Decisions Coming Up at Stem Cell Agency
San Diego Biotech Firm Appeals Rejection of Cancer Stem Cell Grant
Burnham's Lipton Appeals Rejection of $5 Million Grant Application
Conflict of Interest: CIRM to End Contract with Consultant Linked to Grant Recipient
Scripps CEO Joins Stem Cell Agency Board; Love Leaves
$95 Million in California Stem Cell Grants: Preview the Spending
IP to Grant Oversight: Study Calls for Host of Improvements at California Stem Cell Agency
California Budget Slashing Misses Stem Cell Agency
StemCells, Inc., Hoping for as Much as $40 Million from California Stem Cell Agency
$2.4 Million for State Stem Cell Lawyers: Too Much or Not Enough?
Biotech Biz Alert: California Stem Cell Agency Altering Loan Policies
Advisor to CIRM Nominated to Board of CIRM Grant Recipient Expecting $5 Million from Agency
Kudos to CIRM: Stem Cell Agency Sticks with Full Financial Disclosure
Researcher Alert: First Look at Proposed Rules for California's Stem Cell Bank
ACT and CIRM Together on Eye Research Webinar
California Stem Cell Agency Wants to Weaken Financial Disclosure for Execs and Board
Text of CIRM Response on the Weakening of Financial Disclosure Requirements
California Stem Cell Agency Launches $30 Million Plan to Lure Industry
CEO of Biotime's Comments on Stem Cell Agency and Development of Therapies
Correction: ACT Not Rejected 15 Times by California Stem Cell Agency
California Stem Cell Agency Cited for Improvements in Transparency
California Stem Cell Agency Nixes ACT Grant Applications 15 Times
Center for Genetics and Society: 'Wrong' to Ask for More Billions for Stem Cell Agency
The Search for Stem Cell Cures: Can California's $3 Billion Agency Move Audaciously?
Consumer Watchdog Says 'Serious Consideration' Needed on Continued Cash for State Stem Cell Agency
IOM Performance Review of California Stem Cell Agency Expands Its Reach
Engineering Stem Cells on the Ballot: Chuck Winner and the California Stem Cell Agency
CIRM Budget Moves Forward Despite Objections About Legal Costs
Front Page Coverage of CIRM-backed Research
Trounson on Cancellation of Vatican Appearance: 'I Am Disappointed'
Stem Cell Agency Budget Up for Review on Monday: 7 Percent Increase Proposed
'Scandal' in Vatican Over Stem Cell Conference: Appearances by Trounson and Others Cancelled
CIRM Directors Mulling Changes in Funding Direction
Stem Cell Scientist Impressed by CIRM Oversight Over Huge Grants
More Discussion Upcoming of CIRM Spending Plans
Future Spending Plans of California Stem Cell Agency Coming Up
California Stem Cell Agency Pulls $19 Million Grant
Stem Cell Agency Proposes 7 Percent Budget Hike, Seeks $50 Million in Private Funds
The AP on the California Stem Cell Agency: No Cures, Hazy Future
Coverage of Wednesday's Stem Cell Board Meeting
Researcher Alert: California Stem Cell Agency To Alter How It Administers Grants
CSCR On Hold Until March 20 or Thereabouts
Conflict of Interest: California Stem Cell Agency Releases More Documents in Sladek Violation
Conflict of Interest: Chair of California Stem Cell Agency Grant Review Group Resigns
Conflict of Interest: Text of CIRM and Sladek Comments
Trounson Talks Stem Cells in Qatar
California Stem Cell Agency Waiting Until April for More Cash
The Afterlife of the California Stem Cell Agency: Venture Philanthropy and Big Pharma
IOM's Lagging Effort for Comments on the $3 Billion California Stem Cell Agency
Text of IOM Statement on Efforts at Soliciting Comment on CIRM
ACT's Top Scientist Sells $1.5 Million in Company Stock
CIRM Contracting: $1.3 Million for IT, $887,282 for Legal
Stem Cell Agency on Bee Article and Voter Expectations
Blue-Ribbon Panel Seeks Public Comment on California Stem Cell Agency
Trounson Predicts -- 'Optimistically' -- Successful California Stem Cell Treatments in Five Years
California Stem Cell Agency Seeking More Help on Push for Cures
A $25 Million 'Cautionary Tale': CIRM and Geron
Last Public Hearing in California for CIRM Performance Evaluation Scheduled for April
CGS: Broader Perspective Needed in IOM-CIRM Performance Evaluation
IOM Coming Up Short on Independent Analysis of the California Stem Cell Agency
Text of IOM Responses to Questions about Lack of Independent Analysis
Stem Cell Researchers 'Uneasy" in California
Magazine Survey on CIRM Shows Mixed Results
IOM Panel Ends California Visit With No Mainstream Media Coverage
The California Stem Cell Agency and the ACT Opportunity
LA Times: Deck Stacked at the IOM Hearing
State Controller to Hold Hearing on Stem Cell Agency Finances
Orkin Appointed to IOM-CIRM Performance Review Group
Text of IOM Responses to Questions About Selection of Its CIRM Witnesses
In Rare Negative Vote, CIRM Directors Nix $6.3 Million Grant Application
California to Spend $40 Million for Two Stem Cell Genomic Centers
CIRM Board Meeting About to Resume
CIRM Directors to Take Up Future Funding and Direction of Stem Cell Agency
Two Potential Buyers Eyeing Geron's hESC Business
California Stem Cell Agency Slated for More Bond Funding This Spring
Stem Cell Agency Shying Away From Another Multibillion-dollar Bond Proposal
IOM Holding Hearings on California Stem Cell Agency in San Francisco Jan. 24-25
$40 Million Genomic Research Effort Planned by California Stem Cell Agency
Golden State Stem Cell Agency to Give Away $42,237 an Hour This Year